Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Thomas Hanff and Julio Chirinos.
Thomas Hanff
Connection Strength
1.807
Julio Chirinos
  1. Thrombosis in COVID-19. Am J Hematol. 2020 12; 95(12):1578-1589.
    View in: PubMed
    Score: 0.903
  2. Continuation versus discontinuation of renin-angiotensin system inhibitors in patients admitted to hospital with COVID-19: a prospective, randomised, open-label trial. Lancet Respir Med. 2021 03; 9(3):275-284.
    View in: PubMed
    Score: 0.231
  3. Clinical and Proteomic Correlates of Plasma ACE2 (Angiotensin-Converting Enzyme 2) in Human Heart Failure. Hypertension. 2020 11; 76(5):1526-1536.
    View in: PubMed
    Score: 0.226
  4. Randomized elimination and prolongation of ACE inhibitors and ARBs in coronavirus 2019 (REPLACE COVID) Trial Protocol. J Clin Hypertens (Greenwich). 2020 10; 22(10):1780-1788.
    View in: PubMed
    Score: 0.226
  5. Response by Cohen et al to Letter Regarding Article, "Association of Inpatient Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers With Mortality Among Patients With Hypertension Hospitalized With COVID-19". Circ Res. 2020 06 05; 126(12):e140-e141.
    View in: PubMed
    Score: 0.221
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.